CJC-1295
Symbol Cj · MW 3368 Da
Modified GHRH analog stimulating endogenous growth hormone release.
- Discovered
- 2006
- Half-life
- 1 hour
- Approval
- Not FDA-approved
Reported effects
- GH pulse increase
- Recovery
- Body composition
Overview
CJC-1295 is a synthetic growth hormone-releasing hormone peptide designed to stimulate the body's natural production of growth hormone. Instead of directly supplying growth hormone, CJC-1295 signals the pituitary gland to release more of its own GH. It is commonly discussed for hormone support, recovery, body composition, sleep quality, and age-related growth hormone decline. CJC-1295 without DAC has a shorter duration of action compared with the longer-acting DAC version. As a hormone peptide, its main purpose is to support the growth hormone axis through natural signaling pathways.
How it's taken
- Typical Administration
- Injectable
- Typical Dosage
- No established approved dosage; commonly referenced range is 100–300 mcg per injection
- Typical Frequency
- 1–3 times daily depending on protocol
Research sources
Source links included from peer-reviewed literature and trusted medical journal records for this peptide.
Interested in CJC-1295?
Enter your email and we'll send you a curated list of vendors we trust for sourcing this peptide.
No spam · Unsubscribe anytime
For educational purposes only. Many peptides shown are research compounds and not approved for human use in all jurisdictions.